![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, April 26, 2024 8:56:10 PM
I'm sorry that I can't answer your question. I opted out of the class action. But I would be the first to join a lawsuit against the class action lawyers.
Besides, I think lenz may be demonstrating just how widely it will be accepted into the market, well beyond the covid and oncology indications, where lenz has clinically proven its first-in-class safety and efficacy. I'm glad to see this success being factored into a more rapid and expanded amended version of the Milestone Events. I think that's a truly exciting development, yet it gets absolutely no recognition of its significance by shareholders. I'm sure, though, that investor sentiment will improve sharply, once details of our opportunity are spelled out, letter-by-letter, by management.
Thanks for posting!
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM